Vetter Launches Use-Centered Approach to Improve Injections

News
Article

Vetter anounced the Open Innovation Challenge to examine the applicability of digital trends to injection systems.

Vetter has announced an industry challenge to examine how digital trends can be used in the application of injection systems. The Injection 2.0 program is designed to develop “innovative, future-focused and sustainable solutions” for the injection of medicines that are more streamlined to user needs than current methods by employing a user-centered innovation (UCI) approach.

The challenge, called Injection 2.0, consists of 20 participants in four multi-disciplinary teams who will communicate in injection systems users to create more purposeful injection processes.

Vetter’s Open Innovation Challenge was officially launched on June 7, 2018 at a workshop in Ravensburg, Germany. Ideas resulting from the initiative will be further pursued in the context of Vetter’s innovation process, the company reports in a press statement announcing the program.

Participants, including students, medical and economic professionals, and Vetter staff, will apply Design Thinking, a user-centered innovation method that involves direct communication with users of injection systems, including professional caregivers and patients in healthcare settings such as nursing homes, assisted-living facilities, hospitals, and the home healthcare sector. The campaign will continue until the end of September.

In the first field-work phase, participating teams will interview patients, doctors, and professional caregivers. The information collected will be used to address patient’s conscious and subconscious needs and problems that occur when interacting with injection systems on a regular basis. Based on these results, user-oriented ideas for solutions can be generated.

The Open Innovation Challenge will be conducted with the bwcon Innovation Academy, a European technology network of approximately 600 companies and research establishments.

Source: Vetter

 

Recent Videos
Tore Bergsteiner from MAIN5 details his predictions for how the mega trends will shape the bio/pharma industry in 2025 and beyond.
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content